ProACT Post-Approval Study
Public ClinicalTrials.gov record NCT03767595. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Post Approval Study of the ProACT™ Adjustable Continence Therapy for Men
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The ProACT Post Approval Study is a 5-year prospective, open-label, multi-center study designed to evaluate the long-term incidence of urethral stricture and device erosion after ProACT implantation. In addition, the study will evaluate whether treatment with ProACT affects clinical outcomes after subsequent SUI therapies.
Study identification
- NCT ID
- NCT03767595
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 145 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 50 Years and older
- Sex
- Male
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 19, 2019 (Actual)
- Primary completion
- Dec 31, 2031 (Estimated)
- Completion
- Dec 31, 2031 (Estimated)
- Last update posted
- Oct 6, 2026
2019 – 2031
United States locations
- U.S. sites
- 14
- U.S. states
- 10
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Southern California | Los Angeles | California | 90033 | Recruiting |
| Sutter Health | Santa Barbara | California | 93110 | Recruiting |
| University of Colorado | Denver | Colorado | 80045 | Recruiting |
| University of Florida | Gainesville | Florida | 32610 | Recruiting |
| Urological Research Network Corp | Hialeah | Florida | 33016 | Recruiting |
| Emory University | Atlanta | Georgia | 30322 | Recruiting |
| University of Kansas Medical Center | Kansas City | Kansas | 66103 | Recruiting |
| University of Michigan | Ann Arbor | Michigan | 48109 | Recruiting |
| CentraCare- St. Cloud | Saint Cloud | Minnesota | 56303 | Recruiting |
| CHI Health Research | Omaha | Nebraska | 68124 | Recruiting |
| Lehigh Valley Health Network | Allentown | Pennsylvania | 18103 | Recruiting |
| Allegheny Health Network | Pittsburgh | Pennsylvania | 15212 | Recruiting |
| Urology Partners of North Texas Research Institute | Arlington | Texas | 76017 | Recruiting |
| DHR Health Institute for Research and Development | McAllen | Texas | 78504 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03767595, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 6, 2026 · Synced Oct 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03767595 live on ClinicalTrials.gov.